Zacks Investment Research upgraded shares of EXPONENT INC (EXPO) from UNDERPERFORM to NEUTRAL on April 02, 2013, with a target price of $53.80.
Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on EXPONENT INC (EXPO),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment